<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Tau Pathology &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/tau-pathology/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 12 Dec 2025 18:26:20 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Tau Pathology &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Cerebrolysin’s Neuroprotective Effects in Tau Model Unveiled</title>
		<link>https://bioengineer.org/cerebrolysins-neuroprotective-effects-in-tau-model-unveiled/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 12 Dec 2025 18:25:59 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Cerebrolysin]]></category>
		<category><![CDATA[Pick's Disease]]></category>
		<category><![CDATA[Research Integrity]]></category>
		<category><![CDATA[Retraction]]></category>
		<category><![CDATA[Tau Pathology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/cerebrolysins-neuroprotective-effects-in-tau-model-unveiled/</guid>

					<description><![CDATA[In a notable shift in scientific discourse, a significant retraction has been announced regarding the study focusing on the neuroprotective effects of Cerebrolysin in the context of neurodegenerative diseases. The original research was aimed at exploring how this compound could impact the progression of various tauopathies, including the rare but devastating Pick’s disease and other [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">306877</post-id>	</item>
	</channel>
</rss>
